Quick Answer
Teladoc Health, Inc. reported R&D Expense of $277.92 million for fiscal year 2025.
Teladoc Health, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $277.92M | -9.6% |
| 2024 | $307.27M | -11.8% |
| 2023 | $348.52M | +4.5% |
| 2022 | $333.63M | +7.0% |
| 2021 | $311.88M | +89.1% |
| 2020 | $164.94M | +155.2% |
| 2019 | $64.64M | +18.9% |
| 2018 | $54.37M | +57.8% |
| 2017 | $34.46M | +58.0% |
| 2016 | $21.82M | +53.5% |
| 2015 | $14.21M | +87.6% |
| 2014 | $7.57M | +114.4% |
| 2013 | $3.53M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $67.57M | -6.6% | -1.8% |
| June 30, 2025 | $68.78M | -10.4% | -1.7% |
| March 31, 2025 | $69.96M | -14.0% | -3.4% |
| September 30, 2024 | $72.38M | -14.1% | -5.7% |
| June 30, 2024 | $76.75M | -12.1% | -5.7% |
| March 31, 2024 | $81.39M | -6.4% | -3.4% |
| September 30, 2023 | $84.29M | -0.4% | -3.5% |
| June 30, 2023 | $87.31M | +10.9% | +0.4% |
- Teladoc Health, Inc. showed a decrease of -9.6% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Teladoc Health, Inc.’s r&d expense has grown by 7768.7% (from $3.53 million to $277.92 million).
- The most recent figure is from Teladoc Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: